National Center for Advancing Translational Sciences in Maryland
National Center for Advancing Translational Sciences (93.350) awarded $76.1 million to recipients in Maryland in 37 grants from fiscal 2021 to 2025, 2.5% of the program's national total. The Johns Hopkins University received the most, $70.7 million.
- Awarded in Maryland$76.1 million
- Awards37
- Share of the program2.5%
- Rank among states12th of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 11 | $16.2 million |
| FY 2022 | 15 | $16.8 million |
| FY 2023 | 13 | $15.5 million |
| FY 2024 | 8 | $14.6 million |
| FY 2025 | 12 | $13.0 million |
Recipients in Maryland
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Colleges and universities | 20 | $70.7 million |
| I-Cordis, LLC | Small businesses | 1 | $1.5 million |
| Mimetas Us Inc. | Small businesses | 1 | $1.5 million |
| Nostopharma LLC | Small businesses | 2 | $770,982 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Nonprofits | 1 | $750,000 |
| Mountainpass Technology LLC | Small businesses | 1 | $322,526 |
| D4Z4 Medicine, Inc. | Small businesses | 1 | $313,372 |
| Rise Therapeutics LLC | Small businesses | 1 | $282,514 |
| Federation of American Societies for Experimental Biology | Nonprofits | 4 | $30,931 |
| University of Maryland, Baltimore | Colleges and universities | 1 | $24,854 |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to Maryland?
$76.1 million from fiscal 2021 to 2025, across 37 awards. Maryland ranks 12th of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in Maryland?
The largest recipient is The Johns Hopkins University, with $70.7 million in 20 awards. Next are I-Cordis, LLC and Mimetas Us Inc..
Can organizations in Maryland apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in Maryland
- Grants to States for Medicaid
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Education Stabilization Fund
- Highway Planning and Construction
- USAID Foreign Assistance for Programs Overseas
- 1332 State Innovation Waivers
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies